Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
The ovary is a dynamic organ that undergoes some of the most dramatic changes in structure and function of any adult human tissue ( Fig. 8.1 ). Follicles at all stages of development, from tiny primordial follicles to large preovulatory, Graafian follicles and postovulatory corpora lutea coexist throughout the reproductive lifespan. These structures interact with each other in a paracrine fashion through generation of secretory products including sex steroids and protein hormones. The multiple cellular components within the follicles also interact in a highly integrated manner to control oocyte growth and maturation. This chapter describes the development of female germ cells and follicles; how follicle function is coordinated to support oocyte development and steroidogenesis, ovulation, and the formation of the corpus luteum; and, lastly, the process of ovarian aging.
Primordial germ cells are established in extraembryonic tissues around 3 weeks after fertilization.
Based on studies of mouse germ cell lineage formation, signals delivered by bone morphogenetic proteins (BMPs) mediated by the transcription factor, ZGLP1, and retinoic acid released by surrounding tissues appear to be critical.
Transcription factors, pluripotency factors, ligand/receptor signaling pairs, and microRNAs participate in regulating the development and migration of primordial germ cells.
Primordial germ cells proliferate as they migrate to the gonadal ridge, where they enter the developing ovary.
The primordial germ cell lineage is established early in development, originating in the proximal region of the epiblast and/or the nascent amnion, close to the extraembryonic endoderm in humans. Studies in the mouse revealed that a small number of cells emerge under the influence of inductive signals from the visceral endoderm and extraembryonic ectoderm, delivered by bone morphogenetic protein (BMP)-2, BMP4, and BMP8B, which are members of the TGF-β superfamily (see Chapter 6 ). BMP proteins regulate gene expression involved in the primordial germ cell lineage partly through the evolutionarily conserved transcription factor zinc finger GATA like protein 1 (ZGLP1), which acts synergistically with retinoic acid and its downstream effector, stimulated by retinoic acid (STRA8). , WNT family member 3 (WNT3) must be expressed in the proximal epiblast cells to promote competence to respond to BMP signals. WNT3 signaling induces β-catenin-mediated transcription of the mesodermal transcription factor T (also known as Brachyury ), which activates the expression of downstream genes including Prdm1 (previously known as Blimp1 ), Prdm14 , and Tfap2c that are required for primordial germ cell specification in mice.
Primordial germ cell precursors must express SMAD1, SMAD5, and SMAD8, which are phosphoprotein downstream mediators of BMP signaling. The absence of these SMAD proteins results in a marked reduction in the founder cells of the germ cell lineage. , The Bmp–Smad gene dosage is critical, and distortion of the ratios impairs germ cell development. Mice homozygous for null mutations of the Bmp2 , Bmp4 , Prdm1 , and Prdm14 genes do not generate primordial germ cells.
Identifiable as early as the end of the third week of human gestation by their large size and clear cytoplasm, primordial germ cells contain fewer organelles than the surrounding epiblast cells. , In mice, the expression of the interferon-induced transmembrane proteins Ifitm1, Ifitm3 (previously known as Fragilis ), and Prdm1 signals their emergence, with the expression of Prdm14 and Dppa3 (previously known as Stella ), marking the founder primordial germ cells. , , , PRDM1 coordinates the repression of genes normally expressed in somatic cells, and both PRDM1 and PRDM14 have roles in maintaining primordial germ cell pluripotency. , CBFA2/RUNX1 partner transcriptional co-repressor 2 (CBFA2T2) is a scaffolding protein that is required for PRDM14-mediated gene repression at specific DNA regions of primordial germ cells.
In addition to these protein regulators, there is increasing evidence that microRNAs—short noncoding RNA sequences that regulate gene expression mainly by transcriptional and posttranscriptional gene silencing—also play a role in germ cell specification and follicular development. In the mouse, selective deletion of the RNase III enzyme, Dicer, the key protein involved in microRNA processing, results in oocyte spindle defects and impaired follicular development. LIN28, an RNA-binding protein that represses the Let7 microRNA processing pathway, is expressed in founder primordial germ cells and prevents Let7 -mediated suppression of Prdm1 . Other markers of primordial germ cells include tissue-nonspecific alkaline phosphatase and POU class 5 homeobox 1 (POU5F1, also known as OCT4), a transcription factor present in embryonic stem cells and primordial germ cells.
Although most of the above information regarding how primordial germ cells are specified was derived from experiments in mouse models, a global gene expression analysis of individual human primordial germ cells from 4 to 19 weeks postfertilization indicates that mouse and human primordial germ cell transcripts at comparable developmental stages are similar. For example, human primordial germ cells express POU5F1 , KIT , T , DPPA3 , LIN28A , PRDM1 , and PRDM14 . There are, however, major differences between the mouse and the human. For example, mouse primordial germ cells utilize SOX2 as an upstream transcription factor, whereas human primordial germ cells utilize SOX17 and possibly SOX15.
Once specified, primordial germ cells enter a period of migration and proliferation ( Figs. 8.2 and 8.3 ). In the human, they migrate from the epiblast to the hindgut, and then move through the dorsal mesentery along autonomic nerve fibers and Schwann cells, reaching the genital ridge by approximately 4 weeks postfertilization. , The cells change during this migration from a “resting” morphology, taking on an irregular shape with protrusions and pseudopodia required for active amoeboid movement. ,
Primordial germ cell proliferation is characterized by incomplete cytokinesis, resulting in clusters of cells known as “germ cell cysts” or “oocyte nests” that form a network because of cytoplasmic continuity via intracellular bridges. Genes involved in primordial germ cell proliferation in mice include cytotoxic granule associated RNA binding protein like 1 ( Tial1), and Fanconi anemia, complementation group L ( Fancl ), the gene responsible for the mouse “germ cell-deficient” mutation. , , Fancl encodes a subunit of the Fanconi anemia nuclear protein complex that functions in DNA damage repair. In addition, LIF interleukin 6 family cytokine (also leukemia inhibitory factor, LIF) and related cytokines appear to be responsible, in part, for primordial germ cell proliferation.
The movement of primordial germ cells to the gonadal ridge is under the direction of a number of other genes. In the mouse, the transcription factor LIM homeobox 1 (LHX1) maintains the proper positioning of primordial germ cells in the hindgut. The two interferon-induced transmembrane proteins expressed in primordial germ cells regulate repulsive (IFITM1) and homing (IFITM3) activities involved in the migration process, although these proteins are not essential for the success of migration. , Two ligand/receptor signaling pathways, KIT-ligand/KIT receptor tyrosine kinase and Sdf1 (also known as Cxcl12)/Cxcr4), are required for primordial germ cell migration. Wnt5a , which encodes a secreted morphogen, also provides a migration cue for primordial germ cells. The gonadal ridge is absent or does not develop normally in mice homozygous for null mutations in the transcription factors Wt1, Nr5a1, Lhx1, Lhx9, and Emx2. In addition, nullizygous mice have other abnormalities because some of these genes regulate renal or adrenal development. See Fig. 8.4 for representative genes involved in germ cell and ovarian morphogenesis in mice. Mutations in some of these genes are known to cause premature ovarian insufficiency in women.
The microRNA cluster, miR290-295 , is highly expressed in primordial germ cells, and female mice lacking miR290-295 have premature ovarian failure due to primordial germ cell migration defects. , The downstream targets of these microRNAs have not been identified and could include some of the protein regulators mentioned above. The cell adhesion protein integrin β1 must be expressed on the primordial germ cell surface for a successful migration to the gonadal ridge. Primordial germ cells that migrate to aberrant locations undergo apoptosis and therefore are lost from the future ovarian reserve. A comprehensive database of ovarian genes can be found in the Ovarian Kaleidoscope database ( https://appliedbioinfo.com/ ).
Germ cells play an indispensable role in the induction of gonadal development.
Two functional X chromosomes are required for normal ovarian morphogenesis.
Three competing processes—mitosis, meiosis, and atresia—determine the temporal pattern of germ cell accumulation and decline in the prenatal ovary.
Primordial follicles form around 20 weeks of gestation.
Germ cells play an indispensable role in the induction of gonadal development. In the absence of two functional X chromosomes, as in Turner syndrome (45,X0 or other X chromosome structural abnormalities), primordial germ cells can proliferate and migrate to reach the developing gonad, but the germ cells fail to survive because pregranulosa cells are not maintained. As a result, streak gonads containing only stromal cells are present by the time of birth in classical cases, although some germ cells remain in individuals who are mosaics.
Primordial germ cells that arrive at the gonadal ridge are sexually undifferentiated, but, in females, are known as oogonia. By 6 to 7 weeks of intrauterine life, the oogonia population has expanded by mitosis to reach some 10,000 cells, and it reaches approximately 600,000 cells by 8 weeks of intrauterine life ( Fig. 8.3 ). However, from this juncture, the oogonial endowment is influenced by three concurrent processes: mitosis, meiosis, and oogonial atresia. As a result of the combined impact of these processes, the number of germ cells peaks at 6 to 7 million by 20 weeks of gestation and then declines.
Based on work in the mouse, differentiation toward a female germ cell fate is induced in the fetal ovary by BMP signals arising from mesodermal supporting cells, likely pregranulosa cells. As noted previously, BMP signaling induces the expression of the transcription factor ZGLP1 in female germ cells, but it is not expressed at this time in male germ cells or somatic cells. ZGLP1 activates transcription of a set of genes responsible for processes important for female germ cell differentiation, including oogenesis-specific genes and genes regulating meiotic entry.
Between weeks 8 and 13 of fetal life, some of the oogonia enter prophase of the first meiotic division (see Fig. 8.2 and Chapter 9 ). Entry into meiosis is triggered by the presence of both ZGLP1 and STRA8, a transcription factor that targets a number of genes essential for meiosis. , ZGLP1 and STRA8 also participate in suppressing the primordial germ cell transcription program. Although expression of Stra8 is regulated by retinoic acid, an alternative, nonretinoic acid, activator derived from tissue underlying the fetal gonad may be the trigger. Meiotic entry requires the presence of the RNA binding protein, deleted in azoospermia-like (DAZL), as a “licensing” factor. In addition, a protein named meiosis specific with coiled-coil domain (MEIOC) stabilizes transcripts that encode proteins that function during meiosis. If correctly executed, meiosis appears to provide temporary protection from oogonial atresia. Oogonia that persist beyond the seventh month of gestation without entering meiosis undergo programmed cell death.
Primordial follicle formation is accompanied by oocyte nest breakdown as the intercellular bridges are lost and pregranulosa cells surround the primary oocytes (see Figs. 8.2 and 8.4 ). In mice, primordial follicle formation occurs shortly after birth but in humans, it occurs during the second and third trimesters. This process is coordinated by signaling between the germ cells and somatic cells via the Notch-Jagged and KIT-KIT-ligand pathways. In addition, TATA-box binding protein associated factor 4b (TAF4B), a transcription coactivator that is enriched in the fetal gonads, appears to regulate the timing of oocyte nest breakdown and to be essential for oocyte survival. At midgestation, when the ovarian germ cell endowment is at its apex, two-thirds of the total germ cells are intrameiotic primary oocytes; the remaining one-third are oogonia. The subsequent reduction in germ cell numbers is due, in part, to the declining rate of oogonial mitosis, a process that ends by approximately 7 months of intrauterine life. The reduction in germ cells is also the result of an increasing rate of oogonial atresia, which peaks at about month 5 of gestation, followed by follicular atresia, which begins around the sixth month of gestation. Oogonial atresia may provide organelles such as mitochondria and other cytoplasmic components to the surviving oocytes within the same germ cell cyst via direct transfer. , Apoptosis is believed to be triggered by either a deficiency in survival factors, such as KIT-ligand, LIF, or basic fibroblast growth factor (FGF), or by death-inducing factors, such as Fas ligand, TGF-β, and activin.
Primordial follicles in the human ovary (30–60 μm in diameter) are comprised of a late diplotene primary oocyte (9–25 μm in diameter) surrounded by a single layer of flattened granulosa cells ( Fig. 8.5 ). Follicles at this stage of development are not believed to be influenced by gonadotropins. Primary follicles (>60 μm in diameter) are characterized by a primary oocyte surrounded by a single layer of cuboidal granulosa cells. Secondary follicles (<120 μm) consist of a primary oocyte surrounded by several layers of cuboidal granulosa cells (<600 cells), as shown in Fig. 8.5 .
Inactivating mutations in the oocyte-specific transcription factor, folliculogenesis-specific basic helix-loop-helix (Figla) , prevents the formation of primordial follicles. Mice homozygous for a null mutation in the X-linked zinc finger gene, Zfx, have a reduced number of oocytes, resulting in a diminished reproductive lifespan. Mutations in the Atm gene, the murine homolog of the human ataxia-telangiectasia gene, disrupt gametogenesis at the leptotene stage of meiosis and consequently result in sterility. Missense mutations in genes involved in the synaptonemal complex, like synaptonemal complex central element protein 1 (SYCE1), also cause primary ovarian insufficiency in humans. Disruption of Wnt4/5a signaling in mice alters the expression of steroidogenic enzymes in the ovary, resulting in increased testosterone synthesis and Wolffian duct masculinization, and affects germ cell entry into meiosis. ,
Relentless and irreversible attrition from midgestation onward progressively diminishes the ovarian germ cell complement, leaving approximately 700,000 primordial follicles at birth. This number decreases further to approximately 300,000 by the onset of puberty. Of those follicles, only 400 to 500 ovulate during a reproductive lifespan (see Fig. 8.3 ).
Although embryonic stem cells can give rise to oocyte-like cells and follicle-like structures in culture, the notion that germ cells and follicles can arise in vivo in the mammalian ovary during postnatal life from an oogonial stem cell population and contribute to the ovarian reserve remains controversial. ,
Compared with the fetal testis, the human fetal ovary is generally believed to be steroidogenically quiescent, although cholesterol side-chain cleavage enzyme (CYP11A1) and 17α-hydroxylase/17,20-desmolase (CYP17A1) are detectable. Even though follicles are present in the fetal and infant ovary, their steroidogenic capacity only becomes evident at puberty.
Primordial germ cells undergo extensive reprogramming of their chromatin structure (epigenetic reprogramming) beginning soon after specification and continuing after entry into the developing ovary.
The epigenetic changes include global DNA demethylation and erasure of histone modifications, which remove the inherited somatic cell marks to generate a “naïve” epigenetic state.
Complete erasure of genomic imprints occurs during the reprogramming process in preparation for reestablishing female-specific imprints later during oocyte development.
Dramatic alterations in the epigenetic programming of primordial germ cells are initiated soon after their specification and continue after entry into the developing gonad. Nearly complete DNA demethylation occurs across the entire genome, including the inactive X-chromosome, which allows transcriptional activity to resume. Measurements of DNA methylation in human primordial germ cells reveal almost complete demethylation by 10 to 11 weeks of gestation. , This global demethylation process is in part passive, in other words, simply a consequence of DNA replication in the absence of DNA methyltransferase activity. An enzyme-mediated active demethylation process also occurs in combination with activation of the DNA base excision repair pathway. Posttranslational modifications to DNA-associated histone proteins are either transiently or permanently lost due to a combination of histone replacement by nonmodified histone proteins and repression of histone modifying enzymes such as histone methyltransferases. These modifications are temporally associated with pronounced alterations in nuclear architecture, including chromatin decondensation and an increase in nuclear size. Together, these epigenetic changes serve to almost fully erase the inherited somatic differentiation program, resetting the cells to a “naive” epigenetic state.
A critical step in germ cell development, the modification of genomic imprinting, occurs with these epigenetic reprogramming events. In mammals, there is an absolute requirement for the inheritance of a chromosomal complement from both the mother and the father, and specific genes must be expressed from one allele, not both, for successful development. A tightly orchestrated set of modifications of the maternal and paternal chromatin that include methylation of CpG sequences of specific “imprinted” genes, depending on the parent of origin, results in differential transcriptional regulation. In oogonia, both maternal and paternal imprints are erased, and maternal imprints are later established during oogenesis in the fetal ovary and during oocyte growth ( Fig. 8.6 ). ,
The expression of oocyte-specific genes is essential for normal follicular development.
The oocyte and the somatic cells of the follicle engage in a complex conversation involving the transfer of metabolites through gap junctions and an autocrine and paracrine dialogue, mainly through members of the TGF- β superfamily.
There is a partial blood-follicle barrier that restricts the entry of large molecules (>1 million Da molecular weight) into the follicle antrum.
The ovarian stroma serves as an insulator for growth factors and modulators produced by growing follicles. The composition and mechanical properties of the extracellular matrix in different regions of the ovary are thought to play a role in maintaining follicular quiescence or facilitating follicular growth.
Ovarian function is influenced by neural input and the action of neurotrophic factors and tachykinins.
The oocyte is a large cell with a large, highly transcriptionally active nucleus, also known as the germinal vesicle, and an abundant cytoplasm rich in organelles and proteins. The growing oocyte generates all the components required for ovulation, fertilization, and the early stages of preimplantation embryo development before transcription begins from the newly formed embryonic genome. Essential cytoplasmic components include ribosomes, mitochondria, and maternal mRNAs that are stored for later translation into proteins required for maturation and embryo development. Ribosomes and maternal mRNAs are found in the cytoplasm associated with fibrillar cytoskeletal structures known as cytoplasmic lattices, which are composed of keratins, tubulin, and other highly abundant oocyte proteins. , After transcription ceases in the fully grown oocyte, the nucleus also serves as a storage depot for RNAs and RNA-binding proteins.
Oocytes contain far more mitochondria than somatic cells. , Oocyte mitochondria are also unique in their structure and DNA content relative to somatic cells in that they are spherical, have few cristae, and contain only one to two copies of mitochondrial DNA each. Primordial germ cells begin with about 10 mitochondria, and the numbers of mitochondria increase rapidly throughout germ cell migration to the gonad, entry into meiosis, and primordial follicle formation when the oocytes each contain ∼6000 mitochondria. With the onset of oocyte growth, mitochondrial replication continues, with an estimated 300,000 to 400,000 mitochondria in fully grown human oocytes. At this stage, the mitochondria form aggregates that are tightly associated with smooth endoplasmic reticulum membranes. The substantial number of oocyte mitochondria generate the adenosine triphosphate (ATP) needed to support oocyte development, maturation, fertilization, and early embryo development. Diminished mitochondrial function, in some cases due to mitochondrial DNA mutations, is thought to be a major contributor to reproductive aging and premature ovarian insufficiency.
The growing oocyte expresses a number of genes that are essential for successful follicular development, fertilization, and preimplantation development. Mouse knockout studies have identified several oocyte-specific transcription factors essential for folliculogenesis. Figla, Sohlh1 (spermatogenesis- and oogenesis-specific basic helix-loop-helix 1), and Lhx8 (LIM homeobox 8) appear to be required for the formation of primordial follicles from naked primordial oocytes, whereas Nobox (newborn ovary homeobox) is involved in the transition of primordial to primary follicles (see Fig. 8.4 ). Dazl , Cpeb1 (cytoplasmic polyadenylation element binding protein 1), and Ybx2 (previously known as Msy2 ) encode DNA- or RNA-binding proteins involved in regulating mRNA translation within the oocyte.
Oocyte growth is accompanied by formation of the zona pellucida (ZP), an extracellular matrix surrounding the oocyte. The ZP protects the developing germ cell in the follicle, the ovulated egg in the oviduct, and the preimplantation embryo. It also serves as the initial site of contact with sperm, and after fertilization, becomes a barrier that discourages polyspermy. Three genes have been characterized that encode ZP1 (ZPA), ZP2 (ZPB), and ZP3 (ZPC), which are the main sulfated glycoproteins of the ZP. A polymer of ZP2 and ZP3 proteins forms filaments that are interconnected by ZP1, a minor component of the ZP. FIGLA regulates the coordinated expression of these genes during the oocyte growth phase. Humans and rats have a fourth ZP-1-like subunit (ZP4) that is not expressed in mice.
Mice lacking ZP1 form structurally abnormal ZP and have reduced fecundity. In mice lacking ZP2, a thin ZP forms that is not retained in preovulatory follicles. The antral-stage follicle number is substantially reduced, few eggs are ovulated, and no two-cell-stage embryos can be found in mated animals. Moreover, blastocysts derived from in vitro fertilized oocytes from females lacking ZP2 do not undergo normal development. Mice lacking ZP3 form no ZP despite the expression of the other zona proteins. Few eggs are ovulated, and the females are sterile. As in the ZP2 mutant, in vitro fertilized eggs from ZP3-deficient mice do not develop beyond the blastocyst stage.
Oocytes express growth factors in the TGF-β superfamily that are secreted and regulate the development of the follicle. These factors are described in detail below.
Several oocyte-specific “maternal effect” genes required during preimplantation embryo development have been identified in mouse oocytes. Four of these genes encode proteins that form a “subcortical maternal complex” in oocytes, including Nlrp5 (NACHT; leucine-rich repeat; and PYD-containing 5, also known as MATER ), Khdc3 (KH domain containing 3, also known as Filia ), Ooep (oocyte-expressed protein, also known as Floped ), and Tle6 (transducin-like enhancer of split 6). , Peptidylarginine disulfide isomerase, type VI (PADI6) may also function in this complex based on its similar localization patterns in the oocyte and cleavage stage embryo. Mouse oocytes lacking NLRP5, PADI6, or OOEP do not have cytoplasmic lattices, are defective in their ability to synthesize proteins, and fail to develop following fertilization. , KHDC3 is required in oocytes and early embryos to regulate spindle function; embryos of Khdc3 -null female mice develop poorly because of a high incidence of aneuploidy. Nlrp2 , a gene related to Nlrp5 , is expressed in both oocytes and granulosa cells during folliculogenesis. Maternal NLRP2 is required for successful development in early embryos.
Paralogues of the mouse subcortical maternal complex genes are expressed in human oocytes and likely function similarly. Indeed, women homozygous for a point mutation at a phosphorylation site in TLE6 are sterile due to a failure of embryo cleavage following fertilization. Similarly, human oocytes lacking PADI6 undergo developmental arrest following fertilization.
Zar1 (zygote arrest 1) encodes a cytoplasmic protein required for the transition from fertilized egg to cleaving embryo by an unknown mechanism. Gclm (glutamate-cysteine ligase, modifier subunit) encodes a protein that regulates the synthesis of glutathione, which is critical for controlling cellular redox status. Mouse embryos deficient in maternal GCLM have deficits in their ability to develop to the blastocyst stage. Npm2 (nucleoplasmin 2) encodes a nuclear protein generated before oocyte maturation that affects heterochromatin organization and histone deacetylation. In the absence of NPM2 , ovulation and fertilization occur normally, but there is a complete failure of preimplantation embryo development. Dppa3 ( Stella ), in addition to its role in primordial germ cell specification, is a maternal effect gene required for normal preimplantation embryo development.
The concept that the oocyte plays an important role in follicular function and is far more than a passive inhabitant of the follicle emerged from two observations: (1) that follicular survival depends on the presence of viable germ cells and (2) that removal of the oocyte from an antral follicle is followed by luteinization, indicating that the oocyte produces factors that restrain the terminal differentiation of granulosa cells. , Additional support for this concept was derived from experiments in which midsized oocytes from mouse secondary follicles were transferred by a grafting procedure into primordial follicles. This transfer resulted in a doubling of the rate of development of the primordial follicular cells in the presence of the secondary follicle oocyte.
The effects of the oocyte on follicular growth are mediated in part by closely related members of the TGF-β superfamily that are selectively or specifically produced by the oocyte. These factors, growth differentiation factor (GDF)-9 and BMP15, influence granulosa and theca cell function ( Fig. 8.7 ) (see Chapter 6 ). The importance of GDF9 and BMP15 has been established through genetic manipulation of mice and the discovery of spontaneous mutations in the genes encoding GDF9 and BMP15, which affect follicular dynamics in sheep. , In humans, there is a correlation between higher GDF9 and BMP15 expression and the overall quality of the oocyte and subsequent embryo, and some genetic variants have been proposed to cause primary ovarian dysfunction. ,
GDF9, encoded by a gene on chromosome 5q31.1, is highly expressed by oocytes and, to a lesser extent, by primate granulosa cells. It forms homodimers but also heterodimers with BMP15. The follicles of GDF9-deficient mice arrest in growth at the primary stage, yet the oocytes continue to grow at a faster rate than wild-type oocytes, progressing to advanced stages of differentiation seen in the antral follicles of normal mice. However, there are ultrastructural abnormalities in the interconnections between granulosa cells and oocytes; the oocytes ultimately die, leaving a ribbon of ZP behind. The theca also does not form around the follicles, implicating GDF9 in the organization or proliferation of this follicular component. Studies in the rat also indicate that GDF9 stimulates the growth of primary follicles, consistent with the block to progression at the primary stage in GDF9-deficient mice. ,
GDF9 has a variety of actions on granulosa cells and theca cells that are species-specific, acting at least in part through interaction with the activin-like receptor (ALK)-5 (TGF-βRI) and BMP receptor type 2 (BMPR2) receptor complex. , In rodents, GDF9 stimulates granulosa cell differentiation, including induction of luteinizing hormone (LH) receptors and steroidogenesis. In cumulus cells, GDF9 promotes the expression of hyaluronan synthase 2, pentraxin 3, and tumor necrosis factor inducible gene 6 (TSG6), the latter being proteins that are incorporated into the proteoglycan extracellular matrix of the cumulus oophorus complex. It also suppresses urokinase expression while stimulating prostaglandin-endoperoxide synthase-2 (PTGS2, also known as COX2), prostaglandin synthesis, and progesterone formation. , LH receptor expression is suppressed by GDF9, which would discourage luteinization of the cumulus cells. These actions of GDF9 promote unique phenotypes in the granulosa cells surrounding the oocyte, which are exposed to the highest GDF9 concentrations. GDF9 inhibits human theca cell steroidogenesis in vitro . It also stimulates theca cell proliferation, a finding consonant with the apparent role of GDF9 in the murine ovary in controlling thecal development.
BMP15, also known as GDF9b, encoded by a gene on the X chromosome, is another member of the TGF-β superfamily produced by oocytes. It is related structurally to GDF9 and shares a similar pattern of expression. Targeted deletion of the murine Bmp15 gene causes a modest ovarian phenotype in nullizygous animals of subfertility with diminished ovulation and fertilization rates. However, mice nullizygous for Bmp15 and heterozygous for a Gdf9 mutation have severely impaired fertility, with abnormalities in folliculogenesis and cumulus cell function. Spontaneous point mutations in the ovine Bmp15 gene (e.g., Inverdale and Hanna sheep) result in phenotypes that differ from those in Bmp15 knockout mice. In the heterozygous state, the number of follicles ovulating is increased, and thus there is an increase in fecundity. However, primary ovarian failure, with a phenotype resembling the murine Gdf9 knockout, is observed in ewes homozygous for the mutations. In vitro , BMP15 stimulates granulosa cell mitosis. Thus, its absence in vivo would be predicted to impair follicular growth, which is consistent with the ovarian abnormalities in homozygous mutant sheep.
BMP15 binds to a receptor complex consisting of BMPR1B (ALK6) and BMPRII. A point mutation in BMPR1B in Booroola sheep is associated with an additive increase in ovulation rate based on the copy number of mutant alleles. Targeted deletion of the Bmpr2 gene in mice does not affect follicular development, but it does yield an infertility phenotype because of defects in cumulus cell expansion that prevent in vivo fertilization.
Both BMP15 and KIT-ligand participate in a negative feedback loop: BMP15 stimulates KIT-ligand expression by granulosa cells, whereas KIT-ligand inhibits BMP15 expression in oocytes. In the presence of an oocyte, both BMP15 and KIT-ligand stimulate granulosa cell mitosis. The observations that only the oocyte expresses KIT, and that KIT-ligand suppresses expression of BMP15, a granulosa cell mitogen, suggest that the oocyte must be involved in producing another granulosa cell mitogen.
GDF9 and BMP15 are both synthesized as proproteins that form dimers and are then proteolytically processed to yield the bioactive molecules. Notably, the Inverdale mutation that inactivates BMP15 dramatically impairs the proteolytic processing of both the mutant BMP15 and wild-type GDF9 in coexpressing cells. This observation suggests that the phenotype of the Inverdale sheep may be the result, at least in part, of GDF9 deficiency due to interference by mutant BMP15 with wild-type GDF9 processing. Similarly, cells coexpressing mutant human forms of BMP15 and GDF9 associated with premature ovarian failure have decreased production of the mature proteins, likely because of impaired posttranslational processing. Although both GDF9 and BMP15 homodimers have biological activity, heterodimers of the two proteins are far more bioactive as indicated by their potency in regulating granulosa cell survival, granulosa cell functions that support oocyte metabolism, and cumulus cell expansion during maturation. These findings suggest that GDF9:BMP15 heterodimers, rather than homodimers of the individual proteins, are the essential functional ligands secreted by the oocyte.
Based on studies in murine models, it has been proposed that there are two waves of granulosa cell formation, both originating from the ovarian surface epithelium. The first wave participates in the formation of medullary follicles; the second wave does the same for follicles in the ovarian cortex. The emerging granulosa cells are derived from GATA binding protein 4 (GATA4)-expressing cells. GATA4 works in concert with WNT4, R-spondin 1 (RSPO1), β-catenin (CTNNB1), and Forkhead Box L2 (FOXL2) to establish the fetal granulosa cells and regulate folliculogenesis. The key role of FOXL2 is manifested by human mutations that cause syndromic and nonsyndromic premature ovarian insufficiency.
The cohort of granulosa cells that surrounds each oocyte has an oligoclonal origin, with three to five parent cells estimated to give rise to the full complement of granulosa cells in a mature follicle. Granulosa cells receive no direct blood supply, and because a basal lamina separates them from the vascularized theca interna, there is a relative blood-follicle barrier that restricts the entry of leukocytes and high-molecular-weight substances (such as low-density lipoproteins). The absence of a blood supply also necessitates intimate intercellular contact between neighboring granulosa cells and the oocyte.
Granulosa cells are interconnected by an extensive network of gap junctions, which are important for metabolic exchange and transport of small molecules between neighboring cells. The number of gap junctions per granulosa cell increases as follicles develop, coupling them into a functional syncytium. Moreover, granulosa cells extend cytoplasmic processes through the ZP to form gap junctions with the plasma membrane of the oocyte.
Gap junctions are comprised of hexameric arrays of proteins called connexins. Connexin-37 and connexin-43 are two of the most important follicular connexins, and they form gap junctions with different permeability properties. Connexin-37 is the predominant connexin in the oocyte, whereas connexin-43 predominates in granulosa cells. However, at least the first layer of granulosa cells surrounding the oocyte also expresses connexin-37. Communication between granulosa cells and the oocyte occurs through homotypic connexin-37 gap junctions, whereas gap junctional communication between granulosa cells is via homotypic connexin-43 complexes. Follicle-stimulating hormone (FSH) increases gap junction communication by raising levels of mRNA encoding the main connexins in granulosa cells and oocytes. The number of granulosa cell projections to the oocyte through the ZP is also increased. In addition, TGF-β1 and all-trans retinoic acid synthesized locally by cumulus cells induce connexin-43 expression in granulosa cells.
In antral follicles, oocytes are restrained from resuming meiosis via diffusion of cyclic GMP (cGMP) through gap junctions. The ovulatory surge of LH suppresses connexin-43 mRNA expression and causes mitogen-activated kinase-mediated phosphorylation of connexin-43 protein that ultimately results in gap junction closure and disruption of cell-to-cell metabolic coupling.
The importance of connexins to follicular function was shown in the ovarian phenotype of connexin-37 and connexin-43 knockout mice. , In connexin-37-deficient mice, created by targeting the Gja4 gene that encodes this protein, follicle growth is arrested at the preantral stage; oocyte growth, although it commences, is also subsequently arrested before meiotic competence is achieved, resulting in loss of oocytes and formation of luteinized structures. Connexin-43-deficient mice, created by targeting the Gja1 gene, have an ovarian phenotype characterized by diminished germ cell number and impaired growth of follicles beyond the primary stage. Other connexins are expressed in the ovary, but their specific functions are unknown.
Granulosa cells express receptors for, and respond to, a large number of factors that are either generated locally within the follicle or that enter the follicular compartment from the blood. These include oocyte-derived factors, autocrine/paracrine factors produced by the granulosa cells themselves, products of theca cells, and circulating factors derived from the pituitary and other tissues such as fat. The repertoire of signaling molecules that affect primates as well as other animal granulosa cells in vitro and in vivo beyond FSH and LH is extensive, encompassing hypothalamic factors (e.g., kisspeptin, and gonadotropin-releasing hormone [GnRH]), other pituitary hormones (e.g., growth hormone and prolactin), a large array of growth factors (e.g., epidermal growth factor [EGF] family members, TGFβ family members, and insulin-like growth factors [IGFs]), hormones controlling metabolism (e.g., insulin), vascular tone and angiogenesis (e.g., endothelins and apelin), cytokines (e.g., tumor necrosis factor-α [TNF-α]), and adipokines (e.g., leptin, adiponectin, resistin). Some of these factors have a critical role as documented from the phenotypes associated with mutations in humans or spontaneous or induced gene mutations in animals such as previously described for GDF9 and BMP15. The hierarchical and temporal dominance of the actions of the plethora of factors that can act on granulosa cells has yet to be established.
In addition to the multiple factors that act on the array of receptors expressed on granulosa cells, microvesicles and exosomes participate in communication within the follicle. MicroRNAs are one of the better characterized cargoes of these shed components, which act as rheostats to fine-tune gene expression. ,
The key steroid hormone produced by the preovulatory granulosa cells is estradiol. The synthesis of estrogens requires a collaborative relationship with adjacent theca cells, which produce the immediate precursors (androgens) for the aromatization reaction (see Chapter 4 ). The control of this process is under the direction of LH, acting on thecal elements, and FSH, acting on the granulosa compartment through multiple signaling pathways including protein kinase A and AKT (also known as protein kinase B) ( Fig. 8.8 ; see Chapter 2 ). The actions of LH and FSH are modulated by local factors produced by the somatic cells of the follicle and the oocyte, as noted above, including BMPs.
The two-cell–two-gonadotropin model is a formidable example of the integrated function of the different cellular components of the follicle ( Fig. 8.8 ). Studies of isolated granulosa cells have shown that FSH, but not LH, stimulates estrogen production when the cells are provided with an aromatizable substrate. In contrast, isolated human theca cells do not produce substantial amounts of estrogens but instead secrete dehydroepiandrosterone, androstenedione, and smaller amounts of testosterone when adenylate cyclase activity is stimulated. The aromatase activity of granulosa cells is estimated to be at least 700 times greater in the granulosa cells of large preovulatory follicles than in theca cells, arguing strongly for the cellular compartmentalization of estrogen synthesis outlined in the two-cell–two-gonadotropin model.
Estradiol undergoes metabolism in the ovary, generating a number of hydroxylated molecules (e.g., 2-hydroxyestradiol, 4-hydroxyestradiol), some undergoing further metabolism to methylated steroids by catechol-O-methyl transferase (e.g., 2-methoxyestradiol). These estrogen metabolites display pro- or antiangiogenic activity and influence oocyte maturation and the development of oocyte competence (see Chapter 4 ).
Inhibin, a member of the TGF-β protein superfamily, is a heterodimeric 32-kDa glycoprotein composed of two subunits—α and β—linked by disulfide bonds. There is a single common α subunit, but there are different β subunits, denoted β A and β B (see Chapter 6 ). The αβ A and αβ B heterodimers are named inhibin A and B, respectively. In the ovary, the primary source of inhibin is granulosa cells. The main endocrine role of inhibin, for which it was discovered and named, is to suppress pituitary FSH production. In vitro , inhibin augments LH- and IGF-stimulated androgen production by theca cells, and elevated inhibin production by granulosa cells in polycystic ovary syndrome (PCOS) may contribute to the hyperandrogenemia associated with this condition.
Although both isoforms of inhibin have similar biological properties, their synthesis is regulated differently during the follicular and luteal phases. Inhibin B is secreted mainly during the early follicular phase, with levels decreasing in the midfollicular phase and subsequently declining further after the LH surge. Concentrations of inhibin A are low during the first half of the follicular phase but increase during the midfollicular phase and peak during the luteal phase. The differential production of inhibin A and inhibin B is supported by measurements made on follicles of different sizes that showed that inhibin A levels rise with increasing follicular size while inhibin B levels reach a peak in follicles of 9 to 10 mm. Activins are related TGF-β superfamily members formed of dimers of inhibin subunits (e.g., activin A is a dimer of inhibin A subunits) (see Chapter 6 ). They are produced by granulosa cells and oocytes and appear to have mainly autocrine or paracrine roles in follicular development and corpus luteum function. A binding protein, follistatin, blocks activin activity.
Granulosa cells produce other members of the TGF-β superfamily that have local as well as endocrine roles, including anti-müllerian hormone (AMH, also known as müllerian inhibiting substance), which plays important roles in follicular dynamics by restraining the entry of primordial follicles into the growing pool (see Chapter 6 ). AMH is expressed by granulosa cells at the time primordial follicles are recruited to grow into the preantral stages. It is produced as a preprohormone that is activated by proteolytic processing at the N-terminus. However, the cleaved pro-region remains associated with the mature AMH. The highest AMH expression is observed in preantral and small antral follicles. Consequently, AMH levels in serum reflect the number of growing follicles in the size range of 2 to 9 mm and are used as a biomarker of ovarian reserve. In the mouse ovary, the absence of AMH causes primordial follicles to be recruited more rapidly, resulting in the early exhaustion of the follicular endowment. AMH also reduces the sensitivity of follicles to FSH and the number of LH receptors on granulosa cells. Based on its activities, AMH has been proposed to be involved in the pathophysiology of PCOS (see Chapter 22 ). Although some adult extraovarian tissues express AMH receptors (AMHR2), including the human endometrium and adrenal cortex, the roles of AMH in female reproduction outside of the ovary have yet to be elucidated.
Granulosa cells display different phenotypes within the follicle, depending on their location. The mural granulosa cells located near the basal lamina, granulosa cells lining the antrum, and cumulus granulosa cells each have distinguishing features that are determined, in part, by their relative proximity to the oocyte and theca cells and, consequently the paracrine substances released by the oocyte and theca cells. The mural granulosa cells in the antral follicle express the greatest steroidogenic activity ( Fig. 8.9 ). In addition, mural granulosa cells in the preovulatory follicle have the highest level of LH receptors, but there is heterogeneity in LH receptor expression, with receptors being absent from inner mural cells, and present in 13% to 48% of the outer mural granulosa cells. In contrast, natriuretic peptide receptor 2 (NPR2), which produces the cGMP that inhibits resumption of meiosis, is present throughout the follicle but more concentrated in the cumulus cells.
The cumulus cells encapsulating mature mouse oocytes are more transcriptionally synchronized when compared with cumulus cells surrounding immature oocytes. They have a distinctive molecular signature that includes expression of Slc38a3 , which encodes a sodium-coupled neutral amino acid transporter, and higher expression of AMH and secreted frizzled-related protein-4. Cumulus cells and granulosa cells close to the antrum do not express DNA damage-inducible transcript 4-like (DDIT4L), a suppressor of mechanistic target of rapamycin (mTOR) signaling, whereas mural granulosa cells express high levels of this protein. As a result, the cellular metabolism regulator, mTOR, is activated in the cells closest to the oocyte, which improves the transfer of nutrients to the oocyte and increases oocyte developmental competence.
Cumulus cells proliferate after the LH surge and are active in producing an extracellular matrix consisting of hyaluronan, proteoglycans, and proteoglycan-binding proteins when stimulated by the prostaglandins generated in response to the ovulatory stimulus. The elaboration of this matrix leads to the preovulatory expansion of the cumulus-oocyte complex, which is essential for ovulation. Differential patterns of expression of prostaglandin E (EP) receptors allow granulosa cell subpopulations to respond uniquely to PGE 2 during ovulation (see Chapter 4 ).
Luteinized granulosa cells of the ovulated follicle undergo terminal differentiation to give rise to the large luteal cell population of the corpus luteum. These cells have an increased capacity to synthesize progesterone, resulting from upregulation of the machinery required to acquire cholesterol from the circulating lipoproteins, which now have access to the granulosa-lutein cells because of the neovascularization of the developing corpus luteum. The granulosa-lutein cells also retain the capacity to synthesize estrogens from androgen precursors produced by theca lutein cells.
The theca and interstitial cells are believed to arise from fibroblast-like mesenchymal cells in the stromal compartment. They first appear around follicles that have two or more layers of granulosa cells ( Fig. 8.10 ). , The endocrine component of the theca is derived from cells that are positive for the master steroidogenic transcription factor, steroidogenic factor-1 (SF1). These SF1-positive cells migrate to the ovary from the mesonephros. Fibroblastic theca precursors are derived from the mesenchymal cells of the ovarian medullary region.
Production of GDF9 by the oocyte is required for the development of the theca layer. In the absence of GDF9, theca cells are recruited to surround the follicle but do not undergo proper functional differentiation. The KIT and KIT-ligand system is thought to play a prominent role in the early development of the androgen-producing cells of the ovary and testis. Theca cells express KIT, and researchers have postulated that KIT-ligand produced by granulosa cells is important in organizing the theca layer around the developing follicle. Studies in the mouse indicate that hedgehog signaling also plays a critical role in establishing the theca cell lineage. In response to oocyte GDF9, granulosa cells secrete both desert hedgehog (DHH) and Indian hedgehog (IHH); these ligands promote the recruitment of theca cells to the follicle and support their differentiation, including expression of steroidogenic enzyme genes through activation of the GLI family zinc finger transcription factors.
Theca cells engage in a bidirectional dialogue with granulosa cells through the production of keratinocyte-derived growth factor (KGF) and hepatocyte growth factor (HGF). KGF and HGF, like FSH, stimulate granulosa cells to produce KIT-ligand, whereas KIT-ligand acts on the theca cells to promote expression of KGF and HGF in a positive feedback loop (see Fig. 8.10 ). KIT-ligand, KGF, and HGF achieve their highest concentrations in large antral follicles. As the oocyte expresses KIT, this feed-forward loop also affects oocyte function. Moreover, theca-derived insulin-like factor-3 (INSL3), stimulated by LH and BMP-6, acts as a paracrine and autocrine factor, promoting oocyte maturation and theca cell expression of CYP17A1.
Androgens are the hallmark steroidal product of theca cells. LH is the major driver of thecal cell steroidogenesis, promoting the secretion of DHEA, androstenedione, and, to a lesser extent, testosterone. Although 11-oxo-androgens are thought to be exclusively produced by the adrenal cortex, the detection of these molecules in human follicular fluid at concentrations exceeding plasma levels and the induction of enzymes involved in 11-oxo-androgen synthesis in animal ovaries raises the possibility of an ovarian contribution.
Members of the TGF-β superfamily produced by granulosa cells play key roles in the local control of thecal androgen synthesis. , Bone morphogenetic protein-6 (BMP6) suppresses basal and LH-induced thecal androgen secretion. GDF9 (expressed by granulosa cells and the oocyte) inhibits human thecal androgen synthesis as well. TGF-β, which is produced by both granulosa cells and theca cells, reduces thecal androgen production. In addition, activin A decreases thecal androgen synthesis, while inhibins increase it.
Theca cells of the ovulated follicle are incorporated into the corpus luteum, where they represent the population of small luteal cells (theca lutein cells), expressing the steroidogenic machinery to produce androgen precursors that are transformed by the larger luteal cells derived from the granulosa cells of the luteinizing follicle, which have aromatase activity.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here